TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

FDA Approval Summary: Lifileucel for Unresectable or Metastatic Melanoma Previously Treated with an Anti-PD-1-Based Immunotherapy.

Lianne Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.